Govt Approves Lecanemab, New Drug for Treatment of Alzheimer’s Disease
![](https://japannews.yomiuri.co.jp/wp-content/uploads/2023/02/health-ministry-1.jpg)
The Health, Labor and Welfare Ministry
18:13 JST, September 25, 2023
The Health, Labor and Welfare Ministry on Monday approved the domestic manufacture and sale of Lecanemab, a new drug for the treatment of Alzheimer’s disease.
Lecanemab was jointly developed by Eisai Co. of Japan and Biogen Inc. of the United States. The drug is expected to be covered by health insurance within this year and become available for treatment.
It is the first drug proven to be effective in slowing the progression of Alzheimer’s by removing a substance believed to cause the disease.
"Society" POPULAR ARTICLE
-
Typhoon Shanshan Forms, Slowly Moves Toward Japan; Govt Says Typhoon No. 10 Likely to Approach Japan Next Week
-
Typhoon Ampil Approaching Japan
-
Shizuoka Pref. City Offers Foreigners Free Japanese Language Classes; Aims to Raise Non-Natives to Daily Conversation Level
-
Typhoon No. 10 Forecast to Develop; Move into Pacific Ocean South of Japan on Aug. 26
-
Tokyo Companies Prepare for Ashfall From Mt. Fuji Eruption; Disposal Of Ash, Possibly at Sea, A Major Challenge
JN ACCESS RANKING